{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:32:21Z","timestamp":1790299941280,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011963","name":"European Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>CPT (carnitine palmitoyltransferase) II muscle deficiency is the most common form of muscle fatty acid metabolism disorders. In contrast to carnitine deficiency, it is clinically characterized by attacks of myalgia and rhabdomyolysis without persistent muscle weakness and lipid accumulation in muscle fibers. The biochemical consequences of the disease-causing mutations are still discussed controversially. CPT activity in muscles of patients with CPT II deficiency ranged from not detectable to reduced to normal. Based on the observation that in patients, total CPT is completely inhibited by malony-CoA, a deficiency of malonyl-CoA-insensitive CPT II has been suggested. In contrast, it has also been shown that in muscle CPT II deficiency, CPT II protein is present in normal concentrations with normal enzymatic activity. However, CPT II in patients is abnormally sensitive to inhibition by malonyl-CoA, Triton X-100 and fatty acid metabolites. A recent study on human recombinant CPT II enzymes (His6-N-hCPT2 and His6-N-hCPT2\/S113L) revealed that the wild-type and the S113L variants showed the same enzymatic activity. However, the mutated enzyme showed an abnormal thermal destabilization at 40 and 45 \u00b0C and an abnormal sensitivity to inhibition by malony-CoA. The thermolability of the mutant enzyme might explain why symptoms in muscle CPT II deficiency mainly occur during prolonged exercise, infections and exposure to cold. In addition, the abnormally regulated enzyme might be mostly inhibited when the fatty acid metabolism is stressed.<\/jats:p>","DOI":"10.3390\/ijms18010082","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T10:26:49Z","timestamp":1483439209000},"page":"82","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features"],"prefix":"10.3390","volume":"18","author":[{"given":"Diana","family":"Lehmann","sequence":"first","affiliation":[{"name":"Department of Neurology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle\/Saale, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Motlagh","sequence":"additional","affiliation":[{"name":"Department of Neurology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle\/Saale, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Robaa","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle (Saale), Wolfgang-Langenbeck-Str. 4, 06120 Halle\/Saale, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Zierz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle\/Saale, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","article-title":"Carnitine palmitoyltransferases 1 and 2: Biochemical, molecular and medical aspects","volume":"25","author":"Bonnefont","year":"2004","journal-title":"Mol. Aspects Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.62.1.37","article-title":"Muscle carnitine palmitoyltransferase II deficiency: Clinical and molecular genetic features and diagnostic aspects","volume":"62","author":"Deschauer","year":"2005","journal-title":"Arch. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/mgme.1999.2938","article-title":"Carnitine palmitoyltransferase deficiencies","volume":"68","author":"Bonnefont","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ymgme.2006.08.004","article-title":"Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency","volume":"89","author":"Isackson","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2013.12.026","article-title":"Carnitine palmitoyltransferase II (CPT II) deficiency: Genotype-phenotype analysis of 50 patients","volume":"338","author":"Joshi","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.182.4115.929","article-title":"Muscle carnitine palmityltransferase deficiency and myoglobinuria","volume":"182","author":"DiMauro","year":"1973","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJM197502272920902","article-title":"A disorder of muscle lipid metabolism and myoglobinuria. Absence of carnitine palmityl transferase","volume":"292","author":"Bank","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/0003-4819-88-5-610","article-title":"Recurrent myoglobinuria due to muscle carnitine palmityl transferase deficiency","volume":"88","author":"Reza","year":"1978","journal-title":"Ann. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0002-9343(79)90099-8","article-title":"Familial recurrent rhabdomyolysis due to carnitine palmityl transferase deficiency","volume":"67","author":"Patten","year":"1979","journal-title":"Am. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.31.7.883","article-title":"Carnitine palmityl transferase deficiency: Clinical variability, carrier detection, and autosomal-recessive inheritance","volume":"31","author":"Angelini","year":"1981","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1073\/pnas.89.18.8429","article-title":"Molecular characterization of inherited carnitine palmitoyltransferase II deficiency","volume":"89","author":"Taroni","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM197803092981007","article-title":"Partial deficiency of muscle carnitine palmitoyltransferase with normal ketone production","volume":"298","author":"Hostetler","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jnnp.43.8.679","article-title":"Combined partial deficiency of muscle carnitine palmitoyltransferase and carnitine with autosomal dominant inheritance","volume":"43","author":"Ionasescu","year":"1980","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.30.6.627","article-title":"Partial deficiency of carnitine palmityltransferase: Physiologic and biochemical consequences","volume":"30","author":"Layzer","year":"1980","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1432-1033.1985.tb08913.x","article-title":"Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle","volume":"149","author":"Zierz","year":"1985","journal-title":"Eur. J. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0960-8966(92)90057-D","article-title":"Immunoquantitation of carnitine palmitoyl transferase in skeletal muscle of 31 patients","volume":"2","author":"Vladutiu","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1212\/WNL.34.3.353","article-title":"Myoglobinuria and carnitine palmityltransferase (CPT) deficiency: Studies with malonyl-CoA suggest absence of only CPT-II","volume":"34","author":"Trevisan","year":"1984","journal-title":"Neurology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/BF00190315","article-title":"Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long- and short-chain acylcarnitine and acyl-coenzyme A","volume":"71","author":"Zierz","year":"1993","journal-title":"Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00231124","article-title":"Biochemical evidence for heterozygosity in muscular carnitine palmitoyltransferase deficiency","volume":"72","author":"Zierz","year":"1993","journal-title":"Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/BF00577735","article-title":"Limited trypsin proteolysis renders carnitine palmitoyltransferase insensitive to inhibition by malonyl-CoA in patients with muscle carnitine palmitoyltransferase deficiency","volume":"72","author":"Zierz","year":"1994","journal-title":"Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0014-5793(88)81044-5","article-title":"A case of carnitine palmitoyltransferase ii deficiency in human skeletal muscle","volume":"241","author":"Singh","year":"1988","journal-title":"FEBS Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ng0793-314","article-title":"Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients","volume":"4","author":"Taroni","year":"1993","journal-title":"Nat. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1023\/A:1025947930752","article-title":"Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency","volume":"26","author":"Olpin","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00508-012-0296-9","article-title":"Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency","volume":"124","author":"Joshi","year":"2012","journal-title":"Wien. Klinische Wochenschr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2014.02.011","article-title":"Normal protein content but abnormally inhibited enzyme activity in muscle carnitine palmitoyltransferase II deficiency","volume":"339","author":"Lehmann","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00415-013-6887-1","article-title":"Expanding mutation spectrum in CPT II gene: Identification of four novel mutations","volume":"260","author":"Joshi","year":"2013","journal-title":"J. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.str.2006.01.008","article-title":"The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment","volume":"14","author":"Rufer","year":"2006","journal-title":"Structure"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbalip.2015.10.005","article-title":"Malony-CoA inhibits the S113L variant of carnitine-palmitoyltransferase II","volume":"1861","author":"Motlagh","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1212\/NXG.0000000000000053","article-title":"Stabilization of the thermolabile variant S113L of carnitine palmitoyltransferase II","volume":"2","author":"Motlagh","year":"2016","journal-title":"Neurol. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Yao, M., Cai, M., Yao, D., Xu, X., Yang, R., Li, Y., Zhang, Y., Kido, H., and Yao, D. (2015). Abbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblasts. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119936"},{"key":"ref_31","first-page":"10669","article-title":"Human acetyl-CoA carboxylase 2. Molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms","volume":"272","author":"Baldini","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.nutr.28.061807.155434","article-title":"Malonyl-CoA, a key signaling molecule in mammalian cells","volume":"28","author":"Saggerson","year":"2008","journal-title":"Annu. Rev. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.1016\/S0021-9258(17)34394-6","article-title":"Hepatic malonyl-CoA levels of fed, fasted and diabetic rats as measured using a simple radioisotopic assay","volume":"253","author":"McGarry","year":"1978","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bj2140021","article-title":"Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat","volume":"214","author":"McGarry","year":"1983","journal-title":"Biochem. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2007.09.015","article-title":"Clinical features and new molecular findings in carnitine palmitoyltransferase II (CPT II) deficiency","volume":"266","author":"Corti","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<941::AID-MUS20>3.0.CO;2-Z","article-title":"Molecular analysis in spanish patients with muscle carnitine palmitoyltransferase deficiency","volume":"22","author":"Martin","year":"1999","journal-title":"Muscle Nerve"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<949::AID-MUS23>3.0.CO;2-I","article-title":"Biochemical and molecular correlations in carnitine palmitoyltransferase II deficiency","volume":"22","author":"Vladutiu","year":"1999","journal-title":"Muscle Nerve"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s004310100802","article-title":"\u201cAdult\u201d form of muscular carnitine palmitoyltransferase II deficiency: Manifestation in a 2-year-old child","volume":"160","author":"Gempel","year":"2001","journal-title":"Eur. J. Pediatr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0887-8994(99)00125-3","article-title":"Muscular carnitine palmitoyltransferase II deficiency in infancy","volume":"22","author":"Hurvitz","year":"2000","journal-title":"Pediatr. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-0004.2011.01786.x","article-title":"Allelic and phenotypic heterogeneity in 49 italian patients with the muscle form of CPT-II deficiency","volume":"82","author":"Fanin","year":"2012","journal-title":"Clin. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1179\/016164110X12767786356390","article-title":"Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency","volume":"33","author":"Anichini","year":"2011","journal-title":"Neurol. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0960-8966(99)00096-6","article-title":"Genotype\/phenotype correlation in carnitine palmitoyl transferase II deficiency: Lessons from a compound heterozygous patient","volume":"10","author":"Thuillier","year":"2000","journal-title":"Neuromuscul. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0022-3476(88)80180-X","article-title":"Mutant carnitine palmitoyltransferase associated with myoadenylate deaminase deficiency in skeletal muscle","volume":"112","author":"Reuschenbach","year":"1988","journal-title":"J. Pediatr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.179.4076.899","article-title":"Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: A new syndrome","volume":"179","author":"Engel","year":"1973","journal-title":"Science"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/1\/82\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:25:23Z","timestamp":1760207123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/1\/82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1]]}},"alternative-id":["ijms18010082"],"URL":"https:\/\/doi.org\/10.3390\/ijms18010082","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,3]]}}}